ESMO Preceptorship on Breast Cancer 2026: Munich
ESMO Preceptorship on Breast Cancer 2026 will take place from 10 Jul 2026 to 11 Jul 2026 in Munich, Germany, under the leadership of Co-Chairs Nadia Harbeck (Munich, Germany) and […]
16 events found.
Events
-
-
Munich, Germany Munich, Germany
-
ESMO Course in Medical Oncology for Medical Students 2026
INCLIVA Biomedical Research Institute C. de Menéndez y Pelayo, 4, Valencia, SpainThe ESMO Course in Medical Oncology for Medical Students 2026 is an interactive, four-day residential educational program taking place from July 24 to 28, 2026, in Valencia, Spain. Organized by […]
-
ESMO Guidelines: Real World Cases – Webinar Series: Rectal Cancer 2026
Virtual EventThe ESMO Guidelines: Real World Cases – Rectal Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place on 29 July 2026 at 18:30 CEST. […]
-
-
ESMO Academy 2026
Virtual EventThe ESMO Academy 2026, organized by the European Society for Medical Oncology (ESMO), will take place virtually from 3 August to 12 October 2026. The programme will combine on-demand educational […]
-
The 50th Brno Oncology Days
Brno Exhibition Centre Výstaviště 405/1, Brno, South Moravian Region, Czech RepublicThe 50th Brno Oncology Days (BOD 2026) will take place on September 9–11, 2026, at the Brno Exhibition Centre in Brno, Czech Republic. Organized by the Masaryk Memorial Cancer Institute, the anniversary edition will bring together oncology professionals for three days of multidisciplinary education, scientific discussion, and networking. The programme will cover individual cancer types […]
-
-
ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026
Virtual EventThe ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place live on 2 September 2026 at 18:30 CEST. The session will examine the reliability of current HRD testing, the role of PARP inhibitors in maintenance therapy, and the emerging potential […]
-
Optimising Antibody–Drug Conjugate Safety: Mechanisms, Monitoring and Management of Toxicities 2026
Virtual EventThe “Optimising Antibody–Drug Conjugate Safety: Mechanisms, Monitoring and Management of Toxicities 2026” webinar, organized by the European Society for Medical Oncology (ESMO), will take place on September 9, 2026, at […]
-
Molecular Analysis for Precision Oncology Congress 2026
London, United KingdomThe Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 […]
-
ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026: Zurich
Zurich, SwitzerlandThe ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich, Switzerland, from September 18–19, 2026. Chaired by Natalie Cook and Benedikt Westphalen, this educational course aims to provide oncologists with a comprehensive understanding of the management of these complex diseases, from diagnosis to treatment, according to current […]
-
European School of Oncology’s Master in Sarcoma
Università Campus Bio-Medico di Roma Via Álvaro del Portillo, 21, Rome, ItalyHybrid EventThe ESO Master in Sarcoma is a 15-month academic programme developed by the European School of Oncology in collaboration with the Università Campus Bio-Medico di Roma, designed to advance the clinical and scientific expertise of professionals working in sarcoma management. Awarding 60 ECTS credits upon completion, the programme combines 10 online modules, two in-person seminars, […]
-
ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026
Lugano, SwitzerlandThe ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 29–30 September 2026 in Lugano, Switzerland. The course will focus on managing cancer-related symptoms, cachexia, nutritional needs, treatment toxicities, palliative care, end-of-life preparation, and communication with patients and […]
-
ESMO Guidelines: Real World Cases – Webinar Series: Uveal Melanoma 2026
Virtual EventThe ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday, September 30, 2026, starting at 18:30 CEST. As uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens […]
-
ESMO Guidelines: Real World Cases – Early Stage and Locally Advanced NSCLC 2026
Virtual EventThe ESMO Guidelines: Real World Cases Webinar – Early Stage and Locally Advanced NSCLC 2026, organized by the European Society for Medical Oncology (ESMO), will take place on September 30, 2026, at 6:30 PM CEST (8:30 PM AMT). The webinar will review the latest evidence-based recommendations for early-stage and locally advanced non-small-cell lung cancer (NSCLC), […]
-
-
ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026
Singapore, Republic of SingaporeThe ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on treatment sequencing, the biology of metastatic breast cancer, targeted therapy safety and adverse-event management, and multidisciplinary approaches to improving […]
-
ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC
Singapore, Republic of SingaporeThe ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026, oorganized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC, biomarker-driven treatment using NGS, immunohistochemistry, and liquid biopsy, and emerging therapies such as […]
-
ESMO Deep Dive: The Evolving Landscape in Relapsed Ovarian Cancer 2026
Virtual EventThe ESMO Deep Dive: Gynaecological Cancers – The Evolving Landscape in the Treatment of Relapsed Ovarian Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place […]